Reshaping the Immune Balance - Breakthroughs of CAR-T and Mesenchymal Stem Cell Therapies in Autoimmune Disease

Novel CD7-CAR-T (4SCAR7) for the Treatment of Acute T-lymphoblastic Leukemia

CAR-T Therapy Targeting Brain Tumors From Impossible to Hoping for Long-Term Remission

How many CAR-T infusions are needed for solid tumors？

ASGCT 2020 Abstract：Safety Evaluation of Intracerebral Injection of LentiviralABCD1 for X-ALD Gene Therapy

ASGCT 2020 Abstract：Lentiviral Gene Therapy for Hemophilia B: Exploration of Endothelial Promoters in Mesenchymal Stem Cells

ASGCT 2020 Abstract：Lentiviral Gene Therapy of Hemophilia A: Expression and Functional Comparison of Universal and Tissue-specific Promoters

The COVID-19 vaccine development landscape

Dr. Lung Ji-Chang, President of Shenzhen Genoimmune Medical Institute, in the signing ceremony of the Memorandum of Understanding (MoU) for “Technology Transfer and Application on CAR-T and Gene Therapy” at the Faculty of Medicine Siriraj Hospital

Global CAR T-Cell Therapy Market Analysis Report